Lysine-binding site

A lysine-binding site is a structural feature found on various proteins, characterized by the presence of lysine residues that play crucial roles in molecular recognition and interaction. These sites are integral to numerous biological processes, including protein-ligand binding, enzyme catalysis, DNA binding, and mediating protein-protein interactions. Lysine residues within these sites are also frequently involved in post-translational modifications such as acetylation, methylation, and ubiquitination, which regulate protein function and gene expression. While not a discrete therapeutic target itself, the concept of targeting lysine-binding sites on specific proteins holds significant therapeutic potential. Dysregulation of proteins containing these sites is implicated in various diseases, including cancer, neurodegenerative disorders, and inflammatory conditions. Drug discovery efforts are increasingly focused on developing covalent inhibitors that selectively bind to lysine residues within these sites, offering a novel strategy to modulate protein function with enhanced potency and duration of action. However, challenges remain in achieving high selectivity and minimizing off-target effects due to the widespread presence and nucleophilic nature of lysine.

Other names

Lysine recognition motifLysine interaction domainLysine-targeted covalent binding site

Lysine-binding sites are regions on proteins that interact with lysine residues or molecules mimicking lysine. Drugs targeting these sites can act by forming covalent bonds with specific lysine residues, thereby irreversibly inhibiting or modulating protein function. Alternatively, drugs can competitively bind to these sites, mimicking natural ligands and preventing their interaction, or allosterically modulating the protein's activity. For example, tranexamic acid and epsilon-aminocaproic acid are lysine analogues that bind to lysine-binding sites on plasminogen, inhibiting its activation and thus fibrinolysis.